ScinoPharm Taiwan, Ltd. (TPE:1789)

ScinoPharm Taiwan Revenue

ScinoPharm Taiwan had revenue of 678.51M TWD in the quarter ending June 30, 2026, a decrease of -9.23%. This brings the company's total for the last twelve months to 3.07B, down -3.97% year-over-year. In the year 2025, ScinoPharm Taiwan had annual revenue of 3.16B, down -7.13%. That makes ScinoPharm Taiwan the 23,082nd largest company in the world by revenue and 965th in Taiwan.

• Revenue (ttm): 3.07B
• Revenue Growth: -3.97%
• P/S Ratio: 4.95
• Revenue / Employee: 5.68M
• Employees: 540
• Market Cap: 15.50B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Scinopharm Taiwan, Ltd. 3.11B 88.5%
• Changshu Shenlong 389.67M 11.1%
• Others 15.89M 0.5%

By Geography

Chart

• Asia 950.46M 30.0%
• United States 855.95M 27.1%
• Europe 479.49M 15.2%
• India 438.40M 13.9%
• Taiwan 400.93M 12.7%
• Other 38.20M 1.2%

Fiscal year ended Dec 31, 2025 See the full ScinoPharm Taiwan breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.16B	-242.86M	-7.13%
Dec 31, 2024	3.41B	220.20M	6.91%
Dec 31, 2023	3.19B	-77.96M	-2.39%
Dec 31, 2022	3.26B	501.71M	18.16%
Dec 31, 2021	2.76B	-320.59M	-10.40%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 18, 2026

Data Sources Report a data error